|
|
 Ottawa Life Sciences Cluster announces focus on
commercialization and 2011 investment attraction initiatives
Led by OCRIʼs global marketing team, industry-driven cluster organizes for growth
OTTAWA ON – Sept 20, 2011 – With 93 companies and institutes in a newly released
Capability Directory, an industry-led executive team intent on building
commercialization, and participation in national and international medical devices
conferences, the Ottawa Life Sciences Cluster wants to drive more collaboration among
its companies and the more than 20 institutes and research centres located in the
region.
Read full article
|
|
|
 Twelve Ottawa-area businesses have been named to the PROFIT 200 list of the fastest-growing companies across the country, with two making it into the top 10 per cent of the rankings.
Ottawa, ON: June 2nd, 2011 – "PROFIT Magazine's rankings indicated that the number of local companies showing up among the top 100 fastest-growing doubled to eight from just four in the previous year. In 2010, the number of Ottawa-area firms listed on both the PROFIT 100 and Next 100 totalled nine.
Of those, five made a repeat appearance in this year's PROFIT 200 rankings - toy distributor PlaSmart, custom software solutions maker ThinkWrap, advanced battery manufacturer Panacis Medical, pharmaceutical research services provide Allphase Clinical Research Inc Services" ...
Read full article
|
|
|
|
|
Allphase Clinical Research is awarded 93rd place in the 22nd annual PROFIT100 Fastest-Growing Companies by PROFIT Magazine
 Ottawa, ON: June 2nd, 2010 – Allphase Clinical Research Inc [www.allphaseclinical.com]
announced today that it has ranked 93rd in the 22nd annual PROFIT 100 ranking of Canada’s
fastest-Growing Companies by PROFIT Magazine. In the 2004-2009 period covered by this
year’s ranking, Allphase Clinical Research realized an annual revenue increase of 710%.
 Ranking Canada’s Fastest-Growing Companies by five-year revenue growth, the PROFIT 100
profiles the country’s most successful growth companies. Published in the June issue of
PROFIT and online at PROFIT100.com, the PROFIT 100 is Canada’s largest annual celebration
of entrepreneurial achievement.
Canada’s Fastest-Growing Companies are the poster children for entrepreneurship,
innovation and pure tenacity,” says Ian Portsmouth, editor of PROFIT. “They demonstrate
what it takes to succeed in today’s highly competitive, technology-driven global economy.
|
|
President's Message
|
“Receiving this prestigious recognition as one of the top 100 fastest-growing and most successful
companies in Canada for a 2nd consecutive year, and especially in such challenging times,
clearly demonstrates the confidence our loyal Clients have in the services provided by our
exceptional staff.”
Jeff Smith, President & CEO
|
|
|
|
About Allphase Clinical Research Inc.:
|
As a full-service Clinical Development Organization, Allphase has been providing the BioPharma industry with clinical development strategy and clinical trial management services for over 9 years. Allphase has a strong focus in critical-care indications as well as significant clinical research experience in a wide range of therapeutic areas.
Allphase continues to be a trusted drug development partner by utilizing our collective knowledge and experience to assist our clients in achieving great success with their clinical development programs. Our personnel have a solid foundation in drug development, regulatory requirements, and clinical trial management, which has translated to an unparalleled track record of success that continues to exceed expectations.
|
|
About PROFIT Magazine:
|
|
PROFIT: Your Guide to Business Success is Canada’s preeminent publication dedicated to the management issues and opportunities facing small and mid-sized businesses. For 28 years, Canadian entrepreneurs and senior manag¬ers across a vast array of economic sectors have remained loyal to PROFIT because it’s a timely and reliable source of actionable information that helps them achieve business success and get the recognition they deserve for generat¬ing positive economic and social change. Visit PROFIT online at www.profitmagazine.ca.
|
|
|
Philip Sinclair,PhD
|
Philip Sinclair, PhD - Promoted to Chief Scientific Officer
Ottawa, Ontario March 26, 2010 - Allphase Clinical Research, Inc.®, a full service provider of clinical development
services to the pharmaceutical and biotechnology industry is pleased to announce the
promotion of Philip Sinclair, PhD to the position of Chief Scientific Officer.
Dr. Sinclair contributes over 10 years of scientific experience in drug development to
Allphase Clinical Research, Inc.® , and previously held the position of Director,
Scientific and Clinical Affairs. His work has been published in multiple peer-reviewed
publications and he holds a number of patents in the area of drug metabolism.
Dr. Sinclair offers a wealth of expertise from both the scientific and clinical arenas.
His responsibilities cover a wide range of activities including clinical operations
management, strategic and scientific study design, international regulatory insight,
and study analysis.
Prior to joining to Allphase® in 2006, Dr. Sinclair held various research and
management positions in the biotech industry and has acted as a Research
Consultant for large pharmaceutical organizations in both North America and
Japan. Dr. Sinclair has a PhD in Toxicology and an MSc in Molecular Endocrinology.
Jeff Smith, President and CEO, Allphase Clinical Research, Inc.® states that "Dr. Sinclair
has contributed his remarkable talent as a strategic and scientific thinker to the coveted
reputation of Allphase. Phil has worked tirelessly to ensure that our clients receive the
best guidance and insight this industry can offer, thereby providing significant advantage.
By selecting and promoting the best talent in the industry, Allphase continues to live
up to its imparted reputation as the "Professional Research Organization".
|
|
|
|
Allphase Clinical Research Inc is awarded 46th place in the 21st annual PROFIT100
Fastest-Growing Companies by PROFIT Magazine.
Ottawa, ON: June 2nd, 2009 – Allphase Clinical Research Inc. announced today that it
has ranked 46th in the 21st annual PROFIT 100 ranking of Canada’s Fastest-Growing Companies
by PROFIT Magazine. Ranking Canada’s Fastest-Growing Companies by five-year revenue growth,
the PROFIT 100 profiles the country’s most successful growth companies.
In the 2003-2008 period covered by this year’s ranking, Allphase Clinical Research Inc.
realized annual five year revenue growth of 1,626%. This period was also marked by the
company’s international expansion into the United States.
|
|
|
|
President's Message
|
“We are extremely pleased for this recognition as one of the
fastest-growing companies in Canada. The success of Allphase
has always been due to the hard work and dedication of its loyal
staff leading to an extremely high level of repeat business.”
Jeff Smith, President & CEO
|
|
Jeff Smith, President & CEO - Allphase Clinical Research Inc receiving award from
Ian Portsmouth,
Editor & Associate Publisher - PROFIT 100 Magazine.
|
|